Strata Critical Medical (SRTA) Total Liabilities (2019 - 2026)

Strata Critical Medical has disclosed Total Liabilities across 8 years of filings, most recently posting $41.9 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 35.92% year-over-year to $41.9 million; the TTM figure through Mar 2026 stood at $41.9 million (up 35.92% YoY), while the FY2025 annual figure was $46.4 million, up 33.58% from the prior year.
• Total Liabilities retreated to $41.9 million in Q1 2026, from $46.4 million in the prior quarter.
• Over the last five years, Total Liabilities for SRTA reached as high as $60.6 million in Q4 2023 and fell as low as $30.8 million in Q1 2025.
• The 5-year median for Total Liabilities is $46.4 million (2025), against an average of $46.2 million.
• Annual changes were most pronounced in 2023 — Total Liabilities surged 86.29% — and 2024, when it tumbled 42.71%.
• A 5-year view of Total Liabilities shows it stood at $50.5 million in 2022, then advanced by 19.99% to $60.6 million in 2023, then plunged by 42.71% to $34.7 million in 2024, then surged by 33.58% to $46.4 million in 2025, then decreased by 9.73% to $41.9 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $41.9 million, $46.4 million, and $52.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.